Clinical Development of Radiopharmaceuticals a Theranostic Pairs and Dosimetry Considerations Published 2021-04-15 Download video MP4 360p Recommendations 1:02:19 Chemistry and Manufacturing Requirements for Early Clinical Development: What’s in there? Prove it. 56:24 CMC Considerations for Biotechnology Product Development: A Regulatory Perspective 55:02 Planning for Co-development of Companion Diagnostics 1:51:52 Complex Generics: Nasal and Inhalation Products 1:20:20 Chemistry, Manufacturing Controls (CMC) in an Investigational New Drug (IND) (7/14) REdI 2017 8:05:24 Advancing Generic Drugs Development: Translating Science to Approval 2023 - Day 1 1:19:35 Chemistry, Manufacturing, and Controls (CMC) for an IND (7of14) REdI 2018 1:15:25 Establishment Registration– DRLS Workshop 2020 7:49:25 September 13, 2023 Meeting of the Cardiovascular and Renal Drugs Advisory Committee (CRDAC) 48:50 Getting the Best Dose: The Clinical Pharmacology Studies that Help Achieve this Goal 1:09:42 FDA Study Data Technical Conformance Guide v4.4 - Nov 22, 2019 1:56:15 Understanding FDA Inspections and Data 21:09 In Vitro Release Testing for Complex Generics: A Bioequivalence Perspective 57:37 Risk Evaluation and Mitigation Strategies (REMS) Compliance Program 1:48:21 Establishment Registration and Drug Listing Compliance Program – DRLS Workshop 2020 29:20 FDA Oncology Drug Development Overview – Past to Present 3:27:43 September 11-12, 2023 Meeting of the Nonprescription Drugs Advisory Committee (NDAC) - Day 2 2:19:09 New Approaches for an Integrated Nonclinical-Clinical QT/Proarrhythmic Risk Assessment (1 of 2) 2:25:17 CDER BIMO GCP Compliance and Enforcement 7:58:37 Advancing Generic Drugs Development: Translating Science to Approval 2023 - Day 2 Similar videos 58:14 (4/4) Development of Theranostic Radiopharmaceuticals – Eleni Gourni 18:21 Dosimetry-Based Radiopharmaceutical Therapy (With Dr. Jean-Matheiu Beauregard) - why and how 32:18 What is Theranostics? [L13] 08:48 Theranostics & Radiopharmaceutical Trials 57:57 Getting Ahead of the Evolving Landscape in Radiopharmaceuticals 19:11 Theranostics: the future for prostate cancer treatment is here!! 01:54 A common scenario for clinical use of radiopharmaceuticals 1:36:40 11th webinar: Challenges and developments in the field of therapeutic radiopharmaceuticals 1:01:36 [webinar] Establishing an Expert Network for Your Radiopharmaceutical Drug Development Program 3:05:58 ENIIUSRA Session 3 2:29:59 ENIIUSRA Session 1 19:50 EANM2020 - Dosimetry and Radiobiology of Lu PSMA treatment whole body tumour dose by Dr John Violet 04:38 Lab 2 Radiopharmaceutical kit preparation 12:54 What Next for PSMA Imaging and Theranostic @ #GAP2020 1:10:05 PSMA Scans & Pluvicto (lutetium-177) in 2022 | Geoffrey Johnson, MD, PhD | PCRI Conference 2022 45:15 CANM Radiopharmacy Course GMP in Radiopharmaceutical Production 2:22:52 AFOMP School Webinar Nov 17 2021 More results